Pentoxifylline research progress - Al-Mosawi, Aamir
30,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
15 °P sammeln
  • Broschiertes Buch

Pentoxifylline is a safe and well-tolerated methylxanthine derivative with several pharmacological properties that made a well-established therapy for the treatment of intermittent claudication associated with peripheral vascular diseases. It can reduce blood and plasma viscosity, and plasma fibrinogen while promoting fibrinolysis. It can improve blood filterability by enhancing erythrocyte distensibility and reduce neutrophil activation. Pentoxifylline also has anti-inflammatory effects and was reported to have the potential for retarding the progression of atherosclerosis. The aim of this…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Pentoxifylline is a safe and well-tolerated methylxanthine derivative with several pharmacological properties that made a well-established therapy for the treatment of intermittent claudication associated with peripheral vascular diseases. It can reduce blood and plasma viscosity, and plasma fibrinogen while promoting fibrinolysis. It can improve blood filterability by enhancing erythrocyte distensibility and reduce neutrophil activation. Pentoxifylline also has anti-inflammatory effects and was reported to have the potential for retarding the progression of atherosclerosis. The aim of this book is to describe pentoxifylline research progress in various fields of medicine including nephrology, cardiology, andrology, hepatology, neuropsychiatry, pulmonology, and ophthalmology.
Autorenporträt
Aamir Jalal Al-Mosawi ist beratender Arzt und fachkundiger Ausbilder bei Baghdad Medical City. Er ist Mitglied des Beirats der International Association of Medical Colleges (IAMC). Er war Leiter des irakischen Hauptsitzes des internationalen Gremiums der Kopernikus-Wissenschaftler (2006-2019).